Quotient Ltd
NASDAQ:QTNT 3:59:58 PM EDT
| Market Cap (Intraday) | 357.46M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.94 |
| 50-Day MA | $5.65 |
| 200-Day MA | $6.27 |
Quotient Ltd. Stock, NASDAQ:QTNT
B1, Business Park Terre Bonne, Route de Crassier 13, Eysins, Vaud 1262
Jersey
Phone: +41.22.716.9800
Number of Employees: 418
Description
Quotient Ltd. is a commercial-stage diagnostics company. It provides immunohematology products to hospitals and blood banks. The firm develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland.